Autism clues found in blood and brain scans of young children

NCT ID NCT07400484

Recruiting now Knowledge-focused Sponsor: Chen Li Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compares children with autism spectrum disorder (ASD) to typically developing children, aged 3 to 5 years. Researchers measure a substance called N-CAD in the blood and use a non-invasive brain imaging technique (fNIRS) to look at brain activity during rest and social tasks. The goal is to find differences that could help explain autism and lead to better diagnostic tools.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could help identify biological markers for autism, potentially leading to earlier diagnosis or better understanding of the condition.
What could go wrong: This is an early observational study with only 98 participants, so results may not apply to all children with autism. It does not test any treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ASD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial septal defect autism spectrum disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASD

Contacts and locations

Locations

Growth, Development and Mental health of Children and Adolescence Center
RECRUITING

Chongqing, Chongqing Municipality, 400014, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.